Yan Hu's most recent trade in Atara Biotherapeutics Inc was a trade of 20,300 Common Stock done . Disclosure was reported to the exchange on March 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 20,300 | 52,050 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 02 Mar 2026 | 1,603 | 32,227 (0%) | 0% | 5.1 | 8,145 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 02 Mar 2026 | 377 | 31,850 (0%) | 0% | 5.1 | 1,916 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 02 Mar 2026 | 100 | 31,750 (0%) | 0% | 5.1 | 508 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 02 Mar 2026 | 24 | 33,830 (0%) | 0% | 5.1 | 122 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 17 Nov 2025 | 1,645 | 33,613 (0%) | 0% | 13.2 | 21,691 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 17 Nov 2025 | 85 | 33,528 (0%) | 0% | 13.2 | 1,121 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 17 Nov 2025 | 74 | 33,454 (0%) | 0% | 13.2 | 976 | Common Stock |
| Allbirds Inc (Class A) | Lily Yan Hughes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2025 | 22,222 | 22,222 | - | 0 | Class A Common Stock | |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.61 per share. | 18 Aug 2025 | 1,668 | 35,258 (0%) | 0% | 11.6 | 19,372 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 18 Aug 2025 | 86 | 36,926 (0%) | 0% | 11.6 | 999 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.60 per share. | 18 Aug 2025 | 55 | 37,012 (0%) | 0% | 11.6 | 638 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 16 May 2025 | 2,218 | 37,067 (0%) | 0% | 6.8 | 15,000 | Common Stock |
| Korea Fund Inc | Yan Hu | Director | Purchase of securities on an exchange or from another person at price $ 20.72 per share. | 26 Sep 2023 | 500 | 500 | - | 20.7 | 10,360 | Ordinary Shares |